A drug that halves a woman’s risk of breast cancer continues to work long after they stop taking it, say researchers. Anastrozole blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers. It is already available on the NHS, but researchers at Queen Mary University of London said only a… Read More »
By Michael Le Page A new cancer treatments works by by hurting fast-dividing cellsOksana Krasiuk / Alamy Stock Photo Many cancer treatments work very well in the beginning only to fail later as tumours evolve resistance. But a new generation of therapies are being developed to prevent this. One, called BOS172722, has been shown in… Read More »
Breast cancer in young women is characterised by more aggressive biological features as compared to those arising in older patients but outcomes are good when guideline-recommended treatments are given, according to ESMO Spokesperson Dr. Matteo Lambertini from IRCCS Policlinico San Martino Hospital — University of Genoa, Italy, commenting on results of two studies presented during… Read More »
Media playback is unsupported on your device Breast ironing awareness should be made part of the mandatory school curriculum to protect young girls from abuse, the National Education Union has said. The practice involves ironing a girl’s chest with hot objects to delay breasts from growing, so she does not attract male attention. Conservative MP… Read More »
The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) was given accelerated approval for triple-negative breast cancer that is locally advanced or has spread, cannot be surgically removed, and has cells that have a protein called PD-L1, CNN… Read More »